首页> 外文OA文献 >Genome-Wide Screens for In Vivo Tinman Binding Sites Identify Cardiac Enhancers with Diverse Functional Architectures
【2h】

Genome-Wide Screens for In Vivo Tinman Binding Sites Identify Cardiac Enhancers with Diverse Functional Architectures

机译:体内Tinman结合位点的全基因组筛选可识别具有多种功能架构的心脏增强剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The NK homeodomain factor Tinman is a crucial regulator of early mesoderm patterning and, together with the GATA factor Pannier and the Dorsocross T-box factors, serves as one of the key cardiogenic factors during specification and differentiation of heart cells. Although the basic framework of regulatory interactions driving heart development has been worked out, only about a dozen genes involved in heart development have been designated as direct Tinman target genes to date, and detailed information about the functional architectures of their cardiac enhancers is lacking. We have used immunoprecipitation of chromatin (ChIP) from embryos at two different stages of early cardiogenesis to obtain a global overview of the sequences bound by Tinman in vivo and their linked genes. Our data from the analysis of ~50 sequences with high Tinman occupancy show that the majority of such sequences act as enhancers in various mesodermal tissues in which Tinman is active. All of the dorsal mesodermal and cardiac enhancers, but not some of the others, require tinman function. The cardiac enhancers feature diverse arrangements of binding motifs for Tinman, Pannier, and Dorsocross. By employing these cardiac and non-cardiac enhancers in machine learning approaches, we identify a novel motif, termed CEE, as a classifier for cardiac enhancers. In vivo assays for the requirement of the binding motifs of Tinman, Pannier, and Dorsocross, as well as the CEE motifs in a set of cardiac enhancers, show that the Tinman sites are essential in all but one of the tested enhancers; although on occasion they can be functionally redundant with Dorsocross sites. The enhancers differ widely with respect to their requirement for Pannier, Dorsocross, and CEE sites, which we ascribe to their different position in the regulatory circuitry, their distinct temporal and spatial activities during cardiogenesis, and functional redundancies among different factor binding sites.
机译:NK同源结构域因子Tinman是早期中胚层模式的关键调节因子,与GATA因子Pannier和Dorsocross T-box因子一起,在心脏细胞分化和规范化过程中是关键的心源性因子之一。尽管已经确定了驱动心脏发育的调节相互作用的基本框架,但迄今为止,仅约有十几个参与心脏发育的基因被指定为直接Tinman靶基因,并且缺乏有关其心脏增强剂功能结构的详细信息。我们已经使用了在早期心脏发生的两个不同阶段从胚胎中染色质(ChIP)的免疫沉淀来获得Tinman体内结合的序列及其相关基因的全球概况。我们通过分析〜50个具有较高Tinman占用率的序列的数据显示,大多数此类序列在Tinman活跃的各种中胚层组织中充当增强子。所有的背中胚层和心脏增强剂,但其他一些都不需要锡曼功能。心脏增强剂的特征是Tinman,Pannier和Dorsocross的结合基序各不相同。通过在机器学习方法中采用这些心脏增强剂和非心脏增强剂,我们确定了一种称为CEE的新颖图案作为心脏增强剂的分类器。对Tinman,Pannier和Dorsocross的结合基序以及一组心脏增强剂中的CEE基序的需求进行的体内分析表明,除一个受测增强剂外,Tinman位点都是必不可少的。尽管有时它们在Dorsocross站点上可能会在功能上多余。增强子在对Pannier,Dorsocross和CEE位置的要求方面差异很大,我们将其归因于它们在调节电路中的不同位置,在心脏发生过程中它们独特的时空活动以及在不同因子结合位点之间的功能冗余。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号